NURPF closed Friday higher at $8.87, an increase of 0% from Thursday's close, completing a monthly increase of 0.5666% or $0.05. Over the past 12 months, NURPF stock lost -31.2346%.
NURPF is not paying dividends to its shareholders.
The last earnings report, released on May 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Neuren Pharmaceuticals Limited has completed 1 stock splits, with the recent split occurring on Nov 21, 2017.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on ASX (AUD).